Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 7 of 7 for “"Seamless phase II/III"”.
-
Bayesian decision-theoretic method and semi-parametric approach with applications in clinical trial designs and longitudinal studies
… group sequential – adaptive randomization phase II clinical trial design. The design improves the trial efficiency by increasing statistical power and reducing required sample sizes. The design also increases patients’ individual benefit, because it enhances patients’ opportunities of …
-
Innovative Bayesian Designs for Clinical Trials
… outcomes; 3) an adaptive Bayesian design for seamless phase II/III platform trials with survival endpoints. Extensive simulation studies are performed to evaluate the operating characteristics of the proposed designs under various scenarios.
-
Targeted Therapies: Adaptive Sequential Designs For Subgroup Selection In Clinical Trials
… design that can be applied as a confirmatory seamless Phase II/III design. The design is specified through upper and lower spending functions, defined in terms of calendar times. After the first stage, poorly performing subgroups are eliminated and the remaining population is pooled for the …
-
Confidence Intervals for the Treatment Effects in Adaptive Enrichment Designs
While safety is the primary objective in Phase I designs of pharmacological or novel treatment development clinical trials, the focus shifts to detecting the effectiveness of the experimental treatment in confirmatory seamless Phase II/III designs. The presence of patient heterogeneity in modern …
-
Estimation methods in adaptive treatment-selection designs
Adaptive designs can improve the efficiency of drug development, but further research is needed before some are more widely implemented. One such design is a treatment-selection design, which begins with k treatment arms, but only a subset is carried forward after an interim analysis. The final …
-
Innovative Methods for the Design and Analysis of Phase II Clinical Trials
… clinical trial designs, particularly for phase II trials, which play a critical role in the drug development process. Innovative methods are especially necessary for addressing key challenges in phase II trials in terms of dose-ranging study, patient population selection, and decentralized …
-
Evaluation of Strategies for the Phase II to Phase III Progression in Treatment Discovery
… evaluation of a new treatment through several phases of investigation. After preliminary evaluations of the safety and ethics of further study, promising treatments are studied in preliminary screening trials and then ultimately large, confirmatory trials. Although well developed, the …